Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
72.85
-0.15 (-0.21%)
Feb 6, 2026, 5:35 PM CET

BME:ROVI Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3,7343,2203,2131,9254,1382,099
Market Cap Growth
14.60%0.22%66.93%-53.49%97.10%55.36%
Enterprise Value
3,8193,3403,2231,9024,0662,139
Last Close Price
73.0062.0958.7634.3369.3335.42
PE Ratio
30.8223.5218.869.6427.0334.38
Forward PE
25.1719.0219.7612.7625.7030.76
PS Ratio
5.164.223.872.356.385.00
PB Ratio
5.905.545.913.698.795.62
P/TBV Ratio
6.375.926.283.929.426.18
P/FCF Ratio
33.6340.6854.0410.3037.89278.47
P/OCF Ratio
21.4023.2928.378.1027.6944.79
PEG Ratio
2.691.4213.171.420.840.95
EV/Sales Ratio
5.274.373.892.336.275.09
EV/EBITDA Ratio
21.3316.7313.547.0120.6923.87
EV/EBIT Ratio
25.3718.6914.697.5022.5728.55
EV/FCF Ratio
34.4042.2054.2210.1837.23283.73
Debt / Equity Ratio
0.200.200.120.140.160.20
Debt / EBITDA Ratio
0.690.560.270.260.360.80
Debt / FCF Ratio
1.111.451.100.390.679.87
Asset Turnover
0.810.940.991.010.990.77
Inventory Turnover
0.820.891.071.101.140.95
Quick Ratio
1.300.990.831.041.351.10
Current Ratio
3.023.132.552.122.662.97
Return on Equity (ROE)
20.34%24.33%31.99%40.24%36.24%17.54%
Return on Assets (ROA)
10.46%13.69%16.34%19.68%17.23%8.63%
Return on Invested Capital (ROIC)
16.98%22.00%32.24%43.00%35.96%17.16%
Return on Capital Employed (ROCE)
20.40%26.50%36.60%43.40%33.20%16.60%
Earnings Yield
3.24%4.25%5.30%10.37%3.70%2.91%
FCF Yield
2.97%2.46%1.85%9.71%2.64%0.36%
Dividend Yield
1.28%1.51%1.88%3.77%1.38%1.08%
Payout Ratio
39.48%41.24%40.54%25.55%13.80%15.89%
Buyback Yield / Dilution
-3.73%0.51%3.50%-0.03%-0.37%
Total Shareholder Return
1.27%5.23%2.39%7.27%1.35%0.70%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.